Cargando…
The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension
Mild-to-moderate pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD). It is characterized by narrowing and thickening of the pulmonary arteries, resulting in increased pulmonary vascular resistance (PVR) and ultimately leading to right ventricular dys...
Autores principales: | Ye, Lan, Wang, Bing, Xu, Hu, Zhang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672796/ https://www.ncbi.nlm.nih.gov/pubmed/37999248 http://dx.doi.org/10.3390/metabo13111152 |
Ejemplares similares
-
Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
por: Zeng, Cheng, et al.
Publicado: (2023) -
Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats
por: Lee, Jae Chul
Publicado: (2017) -
Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
por: Muraoka, Naoto, et al.
Publicado: (2019) -
Role of prostaglandin E2 in tissue repair and regeneration
por: Cheng, Hui, et al.
Publicado: (2021) -
Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
por: Mutsaers, Henricus A.M., et al.
Publicado: (2022)